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The chronic fatigue syndrome (CFS) is a disabling disorder of
unknown etiology. The symptomatology of CFS (central fatigue,
impaired concentration, attention and memory) suggests that this
disorder could be related to alterations at the level of the central
nervous system. In this study, we have used an automated and unbiased
morphometric technique to test whether CFS patients display struc-
tural cerebral abnormalities.
We mapped structural cerebral morphology and volume in two cohorts
of CFS patients (in total 28 patients) and healthy controls (in total 28
controls) from high-resolution structural magnetic resonance images,
using voxel-based morphometry. Additionally, we recorded physical
activity levels to explore the relation between severity of CFS symptoms
and cerebral abnormalities.
We observed significant reductions in global gray matter volume in
both cohorts of CFS patients, as compared to matched control
participants. Moreover, the decline in gray matter volume was linked
to the reduction in physical activity, a core aspect of CFS.
These findings suggest that the central nervous system plays a key role
in the pathophysiology of CFS and point to a new objective and
quantitative tool for clinical diagnosis of this disabling disorder.
D 2005 Elsevier Inc. All rights reserved.
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The chronic fatigue syndrome (CFS) is characterized by a
persistent or relapsing unexplained fatigue, of new or definite onset
and lasting for at least 6 months (Fukuda et al., 1994). CFS is
believed to affect roughly half a million people in the United
States, and results in significant personal and economic morbidity.1053-8119/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Available online on ScienceDirect (www.sciencedirect.com).The etiology of CFS is still largely unknown, although infectious,
immunological, neuroendocrine, sleep, and psychological mecha-
nisms have been proposed to play a role (Afari and Buchwald,
2003). Several symptoms associated with CFS suggest a role for
the central nervous system, notably the central fatigue, impair-
ments in concentration, attention and memory, headache, and
unrefreshing sleep. Accordingly, structural (Buchwald et al., 1992;
Cope and David, 1996; Lange et al., 1999; Natelson et al., 1993;
Schwartz et al., 1994a,b) and functional (de Lange et al., 2004;
MacHale et al., 2000; Schmaling et al., 2003) neuroimaging studies
have investigated possible cerebral correlates of CFS.
Studies of brain morphology in CFS have focused on
(subcortical) white matter abnormalities, which manifest them-
selves as foci of bright intensity on T2-weighted MR scans. These
studies provide conflicting evidence for cerebral abnormalities.
Whereas some studies reported an increased number of subcortical
white matter abnormalities associated with CFS (Buchwald et al.,
1992; Lange et al., 1999; Natelson et al., 1993; Schwartz et al.,
1994a), other studies observed equal numbers of white matter
abnormalities in healthy volunteers and CFS patients (Cope et al.,
1995; Cope and David, 1996). An important limitation of these
morphological studies lies in the absence of an automated
procedure. Assessment of cerebral atrophy using human observers
and rating scales has a poor reproducibility among raters and low
inter-rater reliability [on average 50%] (Scheltens et al., 1997).
Secondly, studies that observed MRI abnormalities could not link
the abnormalities to physical CFS markers (Cope et al., 1995)
which makes the functional significance and clinical utility of these
findings uncertain.
In this study, we aimed to investigate brain morphology in CFS
patients by relying on a fully automated observer-independent
procedure, voxel-based morphometry (VBM) (Ashburner and
Friston, 2000). VBM provides an unbiased and validated (Watkins
et al., 2002) technique for measuring cerebral volume and tissue
concentration from high-resolution structural magnetic resonance
images, and it has been used to assess subtle morphological brain
differences in different pathologies (Draganski et al., 2002; May et
al., 1999; Yamasue et al., 2003). Furthermore, we collected data
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subgroup of controls using actigraphic assessment. Patients with
CFS are markedly sedentary (van der Werf et al., 2000). Activity
levels provide a quantitative measure of the severity of this aspect
of CFS, so by acquiring information about the physical activity
level, we could assess the relationship between severity of MRI
abnormalities and physical inactivity within the CFS population.
Having observed significant structural abnormalities in a first
cohort of CFS patients, we tested the reliability of the observation
by replicating the experiment in a second independent cohort of
equal size.Methods
Participants
We studied the experimental effect in two separate cohorts of
patients and matched controls. Since CFS predominantly affects
women (Afari and Buchwald, 2003), and given the differences in
brain morphology and size between men and women (Gur et al.,
1991), we restricted this study to female participants. The first cohort
consisted of 13 female CFS patients (CFS: mean age 28.9 years, SD
6.1, range 19–37) and 15 age-, sex-, and education-matched healthy
controls (HC: mean age 25.7 years, SD 6.5, range 19–42). The
second cohort consisted of 15 older female CFS patients (mean age
43.9 years, SD 14.4, range 24–63) and 13 age-, sex-, and education-
matched healthy controls (mean age 43.4 years, SD 14.1, range 22–
68). All participants took part in the study after giving written
informed consent according to institutional guidelines of the local
ethics committee (CMO region Arnhem-Nijmegen, Netherlands)
and in accordance with the Helsinki Declaration of 1975, as revised
in 1983. Patients and controls were assessed by means of detailed
history and investigation, and computer assessment of question-
naires. The physical activity level of 26 of the CFS patients and 14 of
the HC was assessed by actometer measurements during 2 weeks
preceding scanning. All patients conformed to the US Centers for
Disease Control and Prevention (CDC) criteria for CFS (Fukuda et
al., 1994). Participants who manifested psychiatric comorbodity
(e.g., depression) were excluded from the study. None of the
participants took any drugs that acted on the central nervous system.
We collected information regarding self-reported disease severity
and disease duration in all patients. Self-reported disease severity
was assessed by the Checklist Individual Strength (CIS). The
Checklist Individual Strength (CIS) is a 20-item questionnaire that
measures several aspects of fatigue (Dittner et al., 2004; Vercoulen et
al., 1994). Self-reported disease duration reflects the number of
years the CFS patient felt she had been affected by complaints of
fatigue.
Actigraphic measurements
The actometer (Actilog V3.0) used is a motion-sensing device
that can register and quantify human physical activity (Vercoulen et
al., 1997). The actometer is small and light and has to be worn at
the ankle. The small size makes it suitable for long-term
continuous registrations. The actometer has a piezoelectric sensor
that is sensitive in three directions. Accelerations of the sensor
larger than a predefined threshold are considered as activity and are
stored in an internal memory. Each second, the counter of the
actometer is read and reset by the microcontroller. The integrationcounter is set at 5 min providing every 5 min an activity score that
is stored in the internal memory of the actometer. At the end of the
registration period, data are fed into an external computer.
Participants wore the actometer day and night during at least a
14-day period. In order to retain 12 complete registration days, the
first and last registration days were omitted for the analyses. A
general physical activity score reflected the average physical
activity level over the total 12-day time period and was expressed
in the average number of accelerations per 5-min period.
Imaging protocol
High-resolution anatomical images (voxel size = 1 mm3) of the
whole brain were acquired on a 1.5-T Siemens Sonata whole-body
scanner (Erlangen, Germany) using a magnetization prepared rapid
acquisition gradient echo sequence. Images were analyzed using
VBM (Ashburner and Friston, 2000), a fully automated technique
for computational analysis of differences in global and local gray
and/or white matter volume. This method involved the following
steps: (1) spatial normalization of all images to a standardized
anatomical space by removing differences in overall size, position,
and global shape; (2) extraction of gray and white matter from the
normalized images; (3) correction for volume changes induced by
normalization; and (4) analysis of differences in global and local
gray and white matter volume across the whole brain. We applied
an optimized method of VBM (Ashburner and Friston, 2000; Good
et al., 2001) using the SPM2 package (www.fil.ion.ucl.ac.uk/spm)
and special-purpose scripting tools (http://dbm.neuro.uni-jena.de/
vbm.html). The spatial normalization to the standard anatomical
space was performed in a two-stage process. In the first step, we
registered each image to the International Consortium for Brain
Mapping template (Montreal Neurological Institute, Montreal,
Canada), which approximates Talairach and Tournoux space
(Talairach and Tournoux, 1988). We applied a 12-parameter affine
transformation to correct for image size and position. Regional
volumes were preserved while corrections for global differences in
whole brain volume were made. The normalized images of all
participants were averaged and smoothed with a Gaussian kernel of
8 mm full-width at half-maximum (FWHM) and then used as a
new template with reduced scanner- and population-specific biases.
In the second normalization step, we locally deformed each image
of the whole group to the new template using a nonlinear spatial
transformation. This accounts for the remaining shape differences
between the images and the template and improves the overlap of
corresponding anatomical structures. Finally, using a modified
mixture model cluster analysis, normalized images were corrected
for nonuniformities in signal intensity and partitioned into gray and
white matter, cerebrospinal fluid, and background. To remove
unconnected non-brain voxels (e.g., rims between brain surface
and meninges), we applied a series of morphological erosions and
dilations to the segmented images (Good et al., 2001). To correct
for possible volume changes as a result of the nonlinear spatial
normalization, all images were modulated by multiplying voxel
values in the segmented images by the Jacobian determinants
derived from the spatial normalization step (Good et al., 2001). The
resulting modulated images were smoothed with a Gaussian kernel
of 12 mm FWHM. Global volume was calculated from these
modulated images. Head size was estimated by means of a semi-
automated procedure. First, the original MR scans of each
participant were aligned to a common stereotactic space defined
by the plane passing through the anterior and posterior commis-
Fig. 1. Voxel-based morphometric analysis. Data are shown for one participant of the healthy control group (HC, upper row) and the patient group (CFS, lower
row). We segmented high-resolution anatomical images (left column) into gray matter (GM, middle column), white matter (WM, right column), cerebrospinal
fluid, and non-brain tissue (not shown).
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defined the transverse and sagittal diameters of the skull along
this plane. Head size was calculated as the product of these two
diameters. Self-reported disease severity was taken from the US
Centers for Disease Control and Prevention questionnaire.
Statistical analysis
Global differences in gray and white matter between groups
were assessed with an analysis of covariance (ANCOVA) that
considered age as a confounding covariate. Regional (i.e., voxel-
by-voxel) differences in gray matter between groups were assessed
with t tests using the general linear model, considering age and
total gray matter volume as confounding covariates, and correcting
the results for search volume by using family-wise error correction.
Head size differences were assessed with an analysis of variance
(ANOVA). The correlation between daily physical activity and
gray matter volume was assessed by means of Pearson’s correlation
coefficients.Fig. 2. Gray matter volume. (A) Gray matter volume (in liters; mean F SE)
of two cohorts of patients suffering from the chronic fatigue syndrome
(CFS, in red) and healthy control participants (HC, in green). In both
cohorts, CFS patients have markedly reduced gray matter volumes (GM)
than their healthy counterparts. The second cohort of CFS and HC
participants is older than the first, giving rise to overall lower GM. (B)
Scatterplot of gray matter volume as a function of age in the two CFS and
HC cohorts. Both CFS patients and HC show a similar decline in GM as a
function of age.Results
Fig. 1 shows two examples of high-resolution anatomical
images, and the resulting gray matter (GM) and white matter (WM)
maps derived from the automated segmentation procedure as
described in the Methods section.
Both cohorts of CFS patients showed significant reductions in
gray matter volume (GM) compared to HC [cohort I: F(1,25) = 6.2;
P = 0.019; cohort II: F(1,25) = 8.0; P = 0.009]. When the two
cohorts are put together, the GM reduction remains highly
significant [F(1,53) = 14.5; P b 0.001] and amounts to a reduction
in GM of approximately 8% [95% Confidence Interval: 5–11%]
(Fig. 2A). In terms of age-related changes in GM, both CFS
Fig. 3. Relation between physical activity and gray matter volume. There is
a positive relationship between the amount of general physical activity and
the gray matter volume within the CFS population (in red), but not in the
healthy control group (in green). (*) General physical activity measured
over a 2-week period with a movement-sensing device, expressed in
number of accelerations per 5-min period.
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[F(1,53) = 19.5; P b 0.001] (Fig. 2B). This decline amounts to a
reduction of approximately 2.2 ml/year, a decline that is in line
with previous reports on age-related GM loss (Good et al., 2001).
Across the wide age range of our sample (19–66 years), there was
no indication of group  age interactions [F(1,52) = 1.01; P =
0.32], i.e., the GM reduction observed in the CFS groups was not
due to a faster age-related decline.
We did not detect regionally specific difference in GM (over
and above global GM differences, with a threshold of P b 0.05
corrected for search volume). A further exploratory analysis of
statistical trends (P b 0.2 corrected for search volume) failed to
reveal local foci of reduced GM. Taken together, these findings
suggest that the observed GM reduction in the CFS patient groups
is a global rather than a local phenomenon, although further studies
with larger statistical power might be required to detect subtle focal
structural alterations. White matter volume was not significantly
different between groups [F(1,53) = 2.58; P = 0.114], even when
taking both cohorts together, indicating that the difference between
groups is specific to GM. Overall head size was not significantly
different between HC and CFS patients [F(1,53) = 2.57; P = 0.115],
indicating that the differences between groups measured are not a
by-product of differences in head size.
Within the CFS population, there was a positive correlation
between daily physical activity level and GM (Fig. 3; r = 0.39,
P = 0.026 one-tailed). Conversely, there was no significant
correlation between physical activity level and GM in the control
group (Fig. 3; r = 0.10, P = 0.37 one-tailed). There was no
significant correlation between age and physical activity in the
CFS group (r = 0.11, P = 0.30 one-tailed), which excludes that
the positive correlation between GM and physical activity in CFS
patients is a by-product of age-related effects. There were no
significant correlations between GM and self-reported CFS
duration (r = 0.02, P = 0.46 one-tailed) or CFS severity as
measured by the Checklist Individual Strength (r = 0.20, P = 0.16
one-tailed).Discussion
By using an automated morphometric technique, we were able
to assess group-related differences across the whole brain in anobserver-independent manner. Two independent cohorts of CFS
patients showed a marked decline in gray matter volume (GM),
compared to matched healthy controls. Moreover, although GM
was not related to self-reported disease duration or severity, there
was a relation between the (objectively measured) level of physical
activity and the GM reduction.
The results obtained with this approach corroborate and
complement previous studies that observed cerebral abnormalities
associated with CFS (Buchwald et al., 1992; Lange et al., 1999;
Natelson et al., 1993; Schwartz et al., 1994a). Our findings
appear to provide a reliable somatic marker of CFS, and suggest
that the key to this disease might lay in the central nervous
system. However, given the multidimensional nature of CFS
(Afari and Buchwald, 2003), the relationship between the
structural brain abnormalities in CFS and the etiology of this
disorder may not be straightforward. It is conceivable that the
reduced gray matter volume is a cause of chronic fatigue and the
ensuing physical inactivity. Alternatively, it is also possible that
the gray matter reduction is a consequence of the reduced
physical activity inherent in CFS. In this perspective, recent
reports have suggested direct links between physical exercise and
neurogenesis (Pham et al., 2003; van Praag et al., 1999).
However, the latter scenario is not immediately compatible with
the fact that the GM decrease is not correlated with CFS duration.
Future research is clearly warranted to assess whether the present
results can be validated in bigger CFS populations and whether
the changes we observe can be influenced by therapeutic
intervention.
In conclusion, we found substantial and consistent reductions in
GM volume in two independent cohorts of CFS patients. This GM
reduction was associated to the decline in physical activity in the
CFS patients. These findings suggest that the central nervous
system plays a crucial role in the etiology of CFS. Furthermore,
they provide a new objective and quantitative diagnostic marker of
this disabling disorder.Acknowledgments
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